Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

383
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

36
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
36
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

36
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

103
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
103
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

27
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

66
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Analysis of Conventional and Focused Data Augmentation Methods in Rib Fracture Detection in CT Images.

Diagnostics (Basel, Switzerland)·2025
Same author

Automatic Detection of Occluded Main Coronary Arteries of NSTEMI Patients with MI-MS ConvMixer + WSSE Without CAG.

Diagnostics (Basel, Switzerland)·2025
Same author

The role of irisin and cytokines in the etiology of parotid tumors.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2025
Same author

MI-CSBO: a hybrid system for myocardial infarction classification using deep learning and Bayesian optimization.

Computer methods in biomechanics and biomedical engineering·2024
Same author

Spexin level in acute myocardial infarction in the emergency department.

Journal of medical biochemistry·2023
Same author

Increased ghrelin and decreased leptin levels in patients with antisocial personality disorder.

Journal of affective disorders·2022

Related Experiment Video

Updated: Oct 1, 2025

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

11.0K

Eotaxin-1 Levels in Patients with Myocardial Infarction.

Mehmet Kalayci, Evrim Gul

    Clinical Laboratory
    |March 7, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Eotaxin-1 levels are elevated in patients with acute myocardial infarction (AMI), suggesting its potential role in diagnosis. This study investigated eotaxin-1 concentrations in AMI patients compared to healthy individuals.

    More Related Videos

    Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
    14:19

    Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

    Published on: October 14, 2016

    11.7K
    Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
    04:41

    Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

    Published on: July 3, 2018

    8.3K

    Related Experiment Videos

    Last Updated: Oct 1, 2025

    Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
    10:01

    Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

    Published on: March 12, 2018

    11.0K
    Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
    14:19

    Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

    Published on: October 14, 2016

    11.7K
    Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
    04:41

    Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

    Published on: July 3, 2018

    8.3K

    Area of Science:

    • Cardiology
    • Immunology
    • Biochemistry

    Background:

    • Acute myocardial infarction (AMI) is a major global health concern.
    • Eotaxin-1, an eosinophil chemoattractant, is implicated in atherosclerosis.
    • Elevated eotaxin-1 is observed in coronary artery disease patients.

    Purpose of the Study:

    • To quantify eotaxin-1 concentrations in patients with AMI.
    • To explore the diagnostic utility of eotaxin-1 in myocardial infarction.

    Main Methods:

    • Enzyme-linked immunosorbent assay (ELISA) was used to measure plasma eotaxin-1.
    • Study included 42 AMI patients and 40 healthy controls.

    Main Results:

    • Plasma eotaxin-1, troponin-I, CK, and CKMB levels were significantly higher in AMI patients.
    • ROC analysis indicated eotaxin-1 sensitivity of 93% and specificity of 48% at 341.6 pg/mL.
    • Troponin I showed 91% sensitivity and 100% specificity at 0.025 µg/L.

    Conclusions:

    • Eotaxin-1 and eosinophils may contribute to coronary artery disease independently of risk factors.
    • Eotaxin-1 shows promise as a diagnostic marker for AMI, complementing existing cardiac markers.